Common Contracts
2 similar Research Collaboration and License Agreement contracts by Biodelivery Sciences International Inc
RESEARCH COLLABORATION AND LICENSE AGREEMENTResearch Collaboration and License Agreement • August 24th, 2022 • England
This Research Collaboration and License Agreement (the “Agreement”) is made as of January 20, 2009. (the “Effective Date”), by and between BioDelivery Sciences International, Inc., a corporation having its principal place of business at 801 Corporate Center, Suite 210, Raleigh, North Carolina 27607, USA (“BDSI”), and THE DRUGS FOR NEGLECTED DISEASES
RESEARCH COLLABORATION AND LICENSE AGREEMENTResearch Collaboration and License Agreement • January 23rd, 2009 • Biodelivery Sciences International Inc • Pharmaceutical preparations • England
This Research Collaboration and License Agreement (the “Agreement”) is made as of January 20, 2009. (the “Effective Date”), by and between BioDelivery Sciences International, Inc., a corporation having its principal place of business at 801 Corporate Center, Suite 210, Raleigh, North Carolina 27607, USA (“BDSI”), and THE DRUGS FOR NEGLECTED DISEASES INITIATIVE, a not-for-profit foundation organized under the laws of Switzerland, having its registered office at 15 chemin Louis-Dunant, 1202 Geneva, Switzerland (“DNDi”). BDSI and DNDi are referred to herein each individually as a “Party” and collectively as the “Parties.”
